Search

Displaying results 5991 - 6000 of 10000 in total
  1. Drug

    Acifluorfen

    go.drugbank.com/drugs/DB07338
    Experimental

    Acifluorfen is a protoporphyrinogen oxidase inhibitor.

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Sulfobutylether-beta-cyclodextrin

    go.drugbank.com/drugs/DB18607
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    4-Nitrophenyl Phosphate

    go.drugbank.com/drugs/DB04214
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Egtazic acid

    go.drugbank.com/drugs/DB19986
    Experimental

    Egtazic acid is a small molecule drug. Egtazic acid has a monoisotopic molecular weight of 380.14 Da.

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Denopamine

    go.drugbank.com/drugs/DB21277
    Experimental

    Denopamine is a small molecule drug. Denopamine has a monoisotopic molecular weight of 317.16 Da.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Cholic Acid

    go.drugbank.com/drugs/DB02659
    ApprovedInvestigational

    A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.

  7. Drug

    VIT-100

    go.drugbank.com/drugs/DB05865
    Experimental

    It is believed that similar effects would be seen in cells isolated from hypertrophic scars. … In preclinical studies, companyl has shown that VIT-100 inhibits the growth of cells taken from multiple keloid biopsies as compared to the same keloidal cells treated with a control.

  8. Drug

    Peptide YY (3-36)

    go.drugbank.com/drugs/DB05004
    Investigational

    It reduces appetite and increases satiety in obese patients.

  9. Drug

    Blonanserin

    go.drugbank.com/drugs/DB09223
    Investigational

    Blonanserin is an atypical antipsychotic approved in Japan in January, 2008. … As a second-generation (atypical) antipsychotic, it is significantly more efficacious in the treatment of the negative symptoms of schizophrenia compared to first-generation (typical) antipsychotics.

  10. Drug

    IGN311

    go.drugbank.com/drugs/DB04988
    Experimental

    IGN311 is a humanized monoclonal antibody (mab) against the Lewis Y carbohydrate antigen, a blood-group-related oligosaccharide.